- UCL Neuroscience rated top by research strength in the REF2014
- $5.9 million boost for SUDEP research
- Secret of tetanus toxicity offers new way to treat motor neuron disease
- Harm to others outweighs harm to self in moral decision making
- Auto anomaly detection for brain imaging awarded £1m grant
- Spinal surgery: OECs studies to start in 2015
- New brain tumour research Centre of Excellence is unveiled
- UCL awarded £13.5 million to advance medical research facilities
- UCL research helps paralysed man to recover function
- Stenting safe and effective for long-term stroke prevention
- Department of Clinical & Experimental Epilepsy re-designated as a WHO Collaborating Centre
- Leonard Wolfson Experimental Neurology Centre open evening
- Brain stimulation to improve cognition in dementia
- Professor Lees receives Jay Van Andel Award for Outstanding Research in Parkinson’s Disease
- Creating brain cells from skin to study Alzheimer's
- Queen Square authors prominent in Brain collection of classic articles
- Toxic proteins implicated in frontotemporal dementia and motor neurone disease
- GCH1 gene and Parkinson’s risk
- Double mutation linked to frontotemporal dementia
- Equation to predict happiness
- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia
- Researchers test whether diabetes drug can help Parkinson’s patients
- Acute optic neuritis: a review and proposed protocol
- Hippocampal subfield size predicts the precision of memory recall
- Immune system implicated in dementia development
- UCL and Chiesi Group announce partnership to develop a novel therapeutic for birth asphyxia
- Professor Golay made a Fellow of the ISMRM
- The new Leonard Wolfson Experimental Neurology Centre (LWENC) has opened for clinical studies and trials
- Professor Rees wins UCLU Student Choice Teaching Award
- New epilepsy treatment offers ‘on demand’ seizure suppression
- Professor Tabrizi and Professor Price elected to Fellowship of the Academy of Medical Sciences.
- Professor Dolan and Professor Friston elected to EMBO membership
- Vitamin B3 treatment for ataxia shows promise in first human trial
- Teaching Awards 2014
- Light-activated neurons from stem cells restore function to paralysed muscles
- UCL and Max Planck Society invest €5m to open world’s first computational psychiatry centre
- Successful launch of new annual leading edge neurology course
- Statins could help control MS
- Professor Hardy awarded Thudichum Medal by Biochemical Society
- Population Screening for vCJD Using a Novel Blood Test
- Chief Medical Officer appoints Professor Rossor as NIHR National Director for Dementia Research
- New partnership between UCLP brain tumour scientists and Brain Tumour Research
- Professor Hardy awarded Dan David Prize for work on the amyloid gene encoding APP
- NIHR award £650,000 for research into rare neurodegenerative and neuromuscular diseases
- Lowering levels of toxic protein reverses abnormalities in cells from patients with Huntington's disease
- BRC awards £700,000 to neuroscience projects
Published: Oct 22, 2014 9:52:00 AM
Published: Sep 16, 2013 1:37:21 PM
Published: Jan 21, 2015 12:20:24 PM
Published: Feb 24, 2014 2:53:53 PM
Published: Jan 8, 2015 5:47:53 PM
Published: Jan 5, 2015 4:35:46 PM
UCL and Max Planck Society invest €5m to open world’s first computational psychiatry centre
3 April 2014
The world’s first centre for computational psychiatry was launched on Tuesday 1st April, following a €5m investment from the Max Planck Society and UCL.
The Max Planck UCL Centre for Computational Psychiatry and Ageing Research will develop computational methods to understand how human cognition works and how it becomes disrupted in psychiatric disorders, such as depression, and how it changes with normal cognitive ageing.
Computational approaches aim to bridge the gap between neuroscience and the phenomena seen in psychiatric disorders, by developing models of how the brain works. The models will then be linked to measurements of behaviour and changes in brain function. This will help to identify the causes of a range of mental health problems so that personalised treatments can be developed.
The Centre will be based between UCL (University College London) and the Max Planck Institute for Human Development in Berlin. It will be led by Professor Ray Dolan FRS, Director at the Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, and Professor Ulman Lindenberger, Director at the Max Planck Institute for Human Development.
The Centre aspires to spearhead new perspectives on psychiatric disorders that will realise major benefits for patients within 5-10 years. One focus will be rethinking the very nature of psychiatric disorders by moving from simply describing them to understanding how they develop. In diseases such as cancer, understanding how different processes give rise to the disease has opened up exciting new personalised treatment strategies. The Centre will aim to do the same for psychiatric diseases. For example, many people think of depression as a single disorder but this umbrella term is likely to cover a number of distinct processes that could be better-treated with personalised therapies.
Professor Ray Dolan FRS
In most countries of the world, the older segment of the adult population is increasing. There is a pressing need to identify and strengthen the environmental conditions and biological mechanisms that favour mental fitness in later adulthood and old age. Maintaining cognitive abilities and postponing or preventing pathologies leading to dementia are key aims in this endeavour. Ageing alters the neurochemistry, anatomy, and functional dynamics of the brain. We will combine advanced brain imaging methods with computational methods to classify and predict aging changes at the individual level.
Professor Ulman Lindenberger
I welcome the commitment and international collaboration from UCL and the Max Planck Society on this ground-breaking initiative that demonstrates the importance of research into mental illness. The new facility will help to address the challenges posed by mental health problems for neuroscience itself and demonstrate the need to harness cutting edge neuroscience to tackle the problem.
Science Minister David Willetts
The opening event at the Royal Society on 1st April featured welcome speeches from key figures including UCL President & Provost Professor Michael Arthur, Max Planck Society President Peter Gruss, Science Minister David Willetts, Professor Ray Dolan and Professor Ulman Lindenberger. The keynote lecture was delivered by Nobel laureate Professor Eric Kandel, Director at The Kavli Institute for Brain Science at Columbia University.
Page last modified on 03 apr 14 11:48